{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:06:55Z","timestamp":1777774015179,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40121-026-01326-3","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:45:52Z","timestamp":1774442752000},"page":"1315-1333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Community Associations in HIV, HBV and HCV Screening and Support for Migrant Populations in France: Results of the D\u00e9PAC Study"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6160-5578","authenticated-orcid":false,"given":"Dulce","family":"Alfaiate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Claude","family":"Tardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Andoum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliviane","family":"Vignissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Djessima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Jovelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-No\u00ebl","family":"Telles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"1326_CR1","unstructured":"World Health Organization. HIV statistics, globally and by WHO region, 2025. 2025. https:\/\/cdn.who.int\/media\/docs\/default-source\/hq-hiv-hepatitis-and-stis-library\/who-ias-hiv-statistics_2025-new.pdf?sfvrsn=5023deae_15. Accessed 22 July 2025."},{"key":"1326_CR2","unstructured":"World Health Organization. Global hepatitis report 2024. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240091672. Accessed 22 July 2025."},{"key":"1326_CR3","unstructured":"UNAIDS. AIDSinfo: global data on HIV epidemiology and response\u2014fact sheets. 2024. https:\/\/aidsinfo.unaids.org\/. Accessed 8 Sept 2025."},{"key":"1326_CR4","unstructured":"Sant\u00e9 publique France. HIV\/AIDS. 2024. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/infections-sexuellement-transmissibles\/vih-sida\/donnees\/#tabs. Accessed 22 July 2025."},{"key":"1326_CR5","unstructured":"Insee. Demography - population at the beginning of the month\u2014metropolitan France: identifier 000436387. 2025. https:\/\/www.insee.fr\/en\/statistiques\/serie\/000436387. Accessed 17 Oct 2025."},{"key":"1326_CR6","unstructured":"Sant\u00e9 publique France. Prevalence of hepatitis\u00a0B. 2019. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/hepatites-virales\/hepatites-b-et-d\/articles\/prevalence-de-l-hepatite-b. Accessed 22 July 2025."},{"key":"1326_CR7","unstructured":"Sant\u00e9 publique France. Prevalence of hepatitis\u00a0C. 2019. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/hepatites-virales\/hepatite-c\/articles\/prevalence-de-l-hepatite-c. Accessed 22 July 2025."},{"key":"1326_CR8","unstructured":"UNAIDS. Understanding measures of progress towards the 95\u201395\u201395 HIV testing, treatment and viral suppression targets. 2023. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/progress-towards-95-95-95_en.pdf. Accessed 8 Sept 2025."},{"key":"1326_CR9","unstructured":"Sant\u00e9 publique France. HIV and HBV infections among Afro-Caribbeans in \u00cele-de-France: high prevalence and insufficient screening. 2019. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/infections-sexuellement-transmissibles\/vih-sida\/documents\/article\/infections-vih-et-vhb-parmi-les-afro-caribeens-d-ile-de-france-des-prevalences-elevees-et-des-depistages-insuffisants. Accessed 8 Sept 2025."},{"key":"1326_CR10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/hiv.13606","volume":"25","author":"DC Krankowska","year":"2024","unstructured":"Krankowska DC, Lourida P, Quirke SM, et al. Barriers to HIV testing and possible interventions to improve access to HIV healthcare among migrants, with a focus on migrant women: results from a European survey. HIV Med. 2024;25:554\u201364.","journal-title":"HIV Med"},{"key":"1326_CR11","doi-asserted-by":"publisher","first-page":"e833","DOI":"10.1016\/S2352-3018(24)00210-8","volume":"11","author":"FV Segala","year":"2024","unstructured":"Segala FV, Di Gennaro F, Frallonardo L, et al. HIV-related outcomes among migrants living in Europe compared with the general population: a systematic review and meta-analysis. Lancet HIV. 2024;11:e833\u201342.","journal-title":"Lancet HIV"},{"key":"1326_CR12","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/hiv.13444","volume":"23","author":"S Collins","year":"2022","unstructured":"Collins S, Namiba A, Sparrowhawk A, et al. Late diagnosis of HIV in 2022: why so little change? HIV Med. 2022;23:1118\u201326.","journal-title":"HIV Med"},{"key":"1326_CR13","first-page":"369","volume":"25","author":"AC Moorman","year":"2019","unstructured":"Moorman AC, Xing J, Rupp LB, et al. Late diagnosis of hepatitis\u00a0C virus infection, 2014\u20132016: continuing missed intervention opportunities. Am J Manag Care. 2019;25:369\u201374.","journal-title":"Am J Manag Care"},{"key":"1326_CR14","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/jgh.16162","volume":"38","author":"G Mnatzaganian","year":"2023","unstructured":"Mnatzaganian G, MacLachlan JH, Allard N, et al. Missed opportunities for diagnosis of hepatitis\u00a0B and C in individuals diagnosed with decompensated cirrhosis or hepatocellular carcinoma. J Gastroenterol Hepatol. 2023;38:976\u201383.","journal-title":"J Gastroenterol Hepatol"},{"key":"1326_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv162","volume":"2","author":"J Bottero","year":"2015","unstructured":"Bottero J, Boyd A, Gozlan J, et al. Simultaneous human immunodeficiency virus-hepatitis\u00a0B-hepatitis\u00a0C point-of-care tests improve outcomes in linkage-to-care: results of a randomized control trial in persons without healthcare coverage. Open Forum Infect Dis. 2015;2:ofv162.","journal-title":"Open Forum Infect Dis"},{"key":"1326_CR16","unstructured":"The Director General of Health. Order of June 16, 2021 setting the conditions for carrying out rapid diagnostic orientation tests for infection by human immunodeficiency viruses (HIV 1 and 2) and infections by hepatitis\u00a0C (HCV) and hepatitis\u00a0B (HBV) viruses, in medico-social or associative settings and other authorized centers and establishments. 2021. https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000043684636. Accessed 8 Sept 2025."},{"key":"1326_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-075315","volume":"14","author":"M Duracinsky","year":"2024","unstructured":"Duracinsky M, Yaya I, Yombo-Kokule L, et al. Development of a risk prediction score for screening for HBV, HCV and HIV among migrants in France: results from a multicentre observational study (STRADA study). BMJ Open. 2024;14:e075315.","journal-title":"BMJ Open"},{"key":"1326_CR18","first-page":"401","volume":"20\u201321","author":"G Delmas","year":"2021","unstructured":"Delmas G, Ndeikoundam Ngangro N, Brouard C, et al. Surveillance SurCeGIDD: d\u00e9pistage et diagnostic du VIH, des h\u00e9patites B et C et des IST bact\u00e9riennes en CeGIDD en 2020 [in French]. Bull Epid\u00e9miol Hebd. 2021;20\u201321:401\u201312.","journal-title":"Bull Epid\u00e9miol Hebd"},{"key":"1326_CR19","unstructured":"Sant\u00e9 publique France. HIV-STI Public Health Bulletin. November 2023. 2023. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/infections-sexuellement-transmissibles\/vih-sida\/documents\/bulletin-national\/bulletin-de-sante-publique-vih-ist.-novembre-2023. Accessed 11 Sept 2025."},{"key":"1326_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad666","volume":"11","author":"N Beard","year":"2024","unstructured":"Beard N, Hill A. Combined \u201ctest and treat\u201d campaigns for human immunodeficiency virus, hepatitis\u00a0B, and hepatitis\u00a0C: a systematic review to provide evidence to support World Health Organization treatment guidelines. Open Forum Infect Dis. 2024;11:ofad666.","journal-title":"Open Forum Infect Dis"},{"key":"1326_CR21","unstructured":"World Health Organization. Consolidated guidelines on differentiated HIV testing services. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240096394. Accessed 25 July 2025."},{"key":"1326_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jtm.12176","volume":"22","author":"I El-Hamad","year":"2015","unstructured":"El-Hamad I, Pezzoli MC, Chiari E, et al. Point-of-care screening, prevalence, and risk factors for hepatitis\u00a0B infection among 3,728 mainly undocumented migrants from non-EU countries in northern Italy. J Travel Med. 2015;22:78\u201386.","journal-title":"J Travel Med"},{"key":"1326_CR23","doi-asserted-by":"publisher","DOI":"10.5334\/aogh.2848","volume":"86","author":"E Ho","year":"2020","unstructured":"Ho E, Michielsen P, Van Damme P, et al. Point-of-care tests for hepatitis\u00a0B are associated with a higher linkage to care and lower cost compared to venepuncture sampling during outreach screenings in an Asian migrant population. Ann Glob Health. 2020;86:81.","journal-title":"Ann Glob Health"},{"key":"1326_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jve.2024.100369","volume":"10","author":"E Ho","year":"2024","unstructured":"Ho E, Vanderlinden A, Govaerts L, et al. Opportunistic screening using point-of-care testing leads to successful linkage to care of HBV-infected migrant populations in a low endemic country. J Virus Erad. 2024;10:100369.","journal-title":"J Virus Erad"},{"key":"1326_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhip.2025.100671","volume":"10","author":"CPB Moonen","year":"2025","unstructured":"Moonen CPB, Brouwers E, den Heijer CDJ, et al. Integrating hepatitis and HIV point-of-care testing into mandatory migrant tuberculosis screening in the Netherlands: a feasibility and acceptability study. Public Health Pract (Oxf). 2025;10:100671.","journal-title":"Public Health Pract (Oxf)"},{"key":"1326_CR26","volume":"10","author":"G Lens-Perol","year":"2025","unstructured":"Lens-Perol G, V\u00e1zquez-Cancela O, Santana-Armas M, et al. Serological vulnerability and active infection detection among recently arrived migrants in Spain: results from a targeted screening program. Trop Med Infect Dis. 2025;10:169.","journal-title":"Trop Med Infect Dis"},{"key":"1326_CR27","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268824000372","volume":"152","author":"S Mann","year":"2024","unstructured":"Mann S, Mougammadou Z, Wohlfahrt J, Elmahdi R. Post-migration HIV acquisition: a systematic review and meta-analysis. Epidemiol Infect. 2024;152:e49.","journal-title":"Epidemiol Infect"},{"key":"1326_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/sextrans-2019-054080","volume":"96","author":"A Gosselin","year":"2020","unstructured":"Gosselin A, Ravalihasy A, Pannetier J, et al. When and why? Timing of post-migration HIV acquisition among sub-Saharan migrants in France. Sex Transm Infect. 2020;96:227\u201331.","journal-title":"Sex Transm Infect"},{"key":"1326_CR29","unstructured":"World Health Organization. Hepatitis\u00a0B. 2025. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed 25 July 2025."},{"key":"1326_CR30","unstructured":"World Health Organization. Hepatitis\u00a0C. 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c. Accessed 25 July 2025."},{"key":"1326_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101243","volume":"52","author":"M Parczewski","year":"2025","unstructured":"Parczewski M, G\u00f6kengin D, Sullivan A, et al. Control of HIV across the WHO European region: progress and remaining challenges. Lancet Reg Health Eur. 2025;52:101243.","journal-title":"Lancet Reg Health Eur"},{"key":"1326_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10198-017-0886-6","volume":"19","author":"M Guillon","year":"2018","unstructured":"Guillon M, Celse M, Geoffard PY. Economic and public health consequences of delayed access to medical care for migrants living with HIV in France. Eur J Health Econ. 2018;19:327\u201340.","journal-title":"Eur J Health Econ"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01326-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01326-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01326-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:34:36Z","timestamp":1777484076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01326-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1326"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01326-3","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dulce Alfaiate has received payment from Gilead, MSD and ViiV for acting as a speaker and consultant and for conference attendance (including registration fees, travel and accommodation), and has been a principal investigator in studies sponsored by GSK and AbbVie. Jean-Claude Tardy has received payment from Gilead, MSD and ViiV for acting as a speaker and consultant and for conference attendance (including registration fees, travel and accommodation). Jean-No\u00ebl Telles and Fran\u00e7ois Durand are employees of Gilead Sciences. Caroline Andoum, Oliviane Vignissi, Ariel Djessima and Thomas Jovelin have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Ethical approval was not required because the study assessed data already collected by the associations and these data had been anonymised at the point of collection. Moreover, the associations provided only pooled data at a group level for the project; no individual patient-level data were provided. In addition, as a result of the anonymisation, written informed consent from the individuals who underwent POC testing was not required for the data collection; all individuals provided oral consent for POC testing.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}